CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($) $ in Thousands	6 Months Ended
	Jan. 31, 2022	Jan. 31, 2021
Cash flows from operating activities:
Net income	$ 510,438	$ 246,829
Adjustments to reconcile net income to net cash provided by (used in) operating activities:
Depreciation	64,285	54,324
Amortization of intangible assets	76,563	56,630
Amortization of debt issuance costs	5,568	5,460
Deferred income tax (benefit) provision	(13,317)	(98)
(Gain) loss on disposition of property, plant and equipment	701	(196)
Stock-based compensation expense	12,986	13,058
Changes in assets and liabilities:
Accounts receivable	(165,085)	(99,282)
Inventories, net	(236,002)	(425,026)
Prepaid income taxes, expenses and other	15,014	(39,226)
Accounts payable	32,848	112,131
Accrued liabilities	8,204	(25,114)
Long-term liabilities and other	(14,151)	11,944
Net cash provided by (used in) operating activities	298,052	(88,566)
Cash flows from investing activities:
Purchases of property, plant and equipment	(117,804)	(48,097)
Proceeds from dispositions of property, plant and equipment	652	1,084
Business acquisitions, net of cash acquired	(781,818)	(310,576)
Net cash used in investing activities	(898,970)	(357,589)
Cash flows from financing activities:
Borrowings on revolving asset-based credit facilities	660,088	213,632
Payments on revolving asset-based credit facilities	(534,035)	0
Proceeds from issuance of senior unsecured notes	500,000	0
Payments on term-loan credit facilities	0	(59,700)
Payments on other debt	(5,965)	(7,522)
Payments of debt issuance costs	(8,445)	0
Regular cash dividends paid	(47,833)	(45,400)
Payments on finance lease obligations	(529)	(244)
Purchases of treasury shares	(58,331)	0
Payments related to vesting of stock-based awards	(18,011)	(8,317)
Short-term financial obligations and other, net	3,821	(5,488)
Net cash provided by financing activities	490,760	86,961
Effect of exchange rate changes on cash and cash equivalents and restricted cash	(8,225)	4,378
Net decrease in cash and cash equivalents and restricted cash	(118,383)	(354,816)
Cash and cash equivalents and restricted cash, beginning of period	448,706	541,363
Cash and cash equivalents and restricted cash, end of period	330,323	186,547
Cash and cash equivalents and restricted cash, total	330,323	186,547
Less: restricted cash	25,080	2,913
Cash and cash equivalents	305,243	183,634
Supplemental cash flow information:
Income taxes paid	151,307	112,425
Interest paid	33,529	39,705
Non-cash investing and financing transactions:
Capital expenditures in accounts payable	$ 5,147	$ 3,422